Isobel Denham

Isobel Denham is a Senior Brand Manager at Incyte since July 2022, previously serving as the Pan-Tumour, Early Assets and Innovation Manager at Bristol Myers Squibb from September 2021 to May 2022. Prior experience includes a role as Product Manager for the Cell Therapy Franchise at Celgene, where Isobel led strategic brand planning, and engagement initiatives across multiple therapeutic areas. Earlier positions at Celgene also included Associate Product Manager and Scientific Affairs Advisor, focusing on CAR T therapies and medical information inquiry handling. Isobel began their career with a work experience stint at Smith & Williamson, gaining insight into trading and investment analysis. Educational qualifications include a Bachelor of Science with Honours in Psychology from The University of Nottingham.